Multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Intervention 1: Intervention group: one hour before bedtime, the lavender extract was put on a cotton ball for 2 to 3 drops every night for 4 weeks and placed at a distance of 10 to 15 centimeters (th
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: All patients with MS who have Expanded Disability Status Scale (EDSS) equal or less than 4. Patients with MS aged 18 to 50 years old Informed consent
Exclusion criteria
Exclusion criteria: Use of other complementary and alternative methods during the study Sleeping and sedative medications, antidepressants and analgesics during the study History of asthma or respiratory diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality with Pittsburgh Sleep Quality Questionnaire. Timepoint: Measurement of sleep quality at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Fatigue with Fatigue Impact Scale MS. Timepoint: Measurement of fatigue at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: Fatigue Impact Scale MS.;Anxiety with State-Trait Anxiety Inventory (STAI). Timepoint: Measurement of anxiety at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: State-Trait Anxiety Inventory (STAI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahimeh Davodabady
Arak University of Medical Sciences
Outcome results
None listed